Terms: = Kidney tumors AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b
97 results:
1. Combination immune checkpoint and targeted protein kinase inhibitors for the treatment of renal cell carcinomas.
Roskoski R
Pharmacol Res; 2024 May; 203():107181. PubMed ID: 38614375
[TBL] [Abstract] [Full Text] [Related]
2. Methionine secreted by tumor-associated pericytes supports cancer stem cells in clear cell renal carcinoma.
Zhang C; Du Z; Gao Y; Lim KS; Zhou W; Huang H; He H; Xiao J; Xu D; Li Q
Cell Metab; 2024 Apr; 36(4):778-792.e10. PubMed ID: 38378000
[TBL] [Abstract] [Full Text] [Related]
3. A novel drug specific mRNA biomarker predictor for selection of patients responding to dovitinib treatment of advanced renal cell carcinoma and other solid tumors.
Knudsen S; Hansen A; Foegh M; Petersen S; Mekonnen H; Jia L; Shah P; Martin V; Frykman G; Pili R
PLoS One; 2023; 18(8):e0290681. PubMed ID: 37647320
[TBL] [Abstract] [Full Text] [Related]
4. PDGF-BB/pdgfrβ induces tumour angiogenesis via enhancing PKM2 mediated by the PI3K/AKT pathway in Wilms' tumour.
Sang BT; Wang CD; Liu X; Guo JQ; Lai JY; Wu XM
Med Oncol; 2023 Jul; 40(8):240. PubMed ID: 37442847
[TBL] [Abstract] [Full Text] [Related]
5. A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma.
Ness DB; Pooler DB; Ades S; Highhouse BJ; Labrie BM; Zhou J; Gui J; Lewis LD; Ernstoff MS
Cancer Med; 2023 Jun; 12(12):13100-13110. PubMed ID: 37148554
[TBL] [Abstract] [Full Text] [Related]
6. Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers.
Jin J; Xie Y; Zhang JS; Wang JQ; Dai SJ; He WF; Li SY; Ashby CR; Chen ZS; He Q
Drug Resist Updat; 2023 Mar; 67():100929. PubMed ID: 36739809
[TBL] [Abstract] [Full Text] [Related]
7. Familial multiple discoid fibromas is linked to a locus on chromosome 5 including the FNIP1 gene.
van de Beek I; Glykofridis IE; Tanck MWT; Luijten MNH; Starink TM; Balk JA; Johannesma PC; Hennekam E; van den Hoff MJB; Gunst QD; Gille JJP; Polstra AM; Postmus PE; van Steensel MAM; Postma AV; Wolthuis RMF; Menko FH; Houweling AC; Waisfisz Q
J Hum Genet; 2023 Apr; 68(4):273-279. PubMed ID: 36599954
[TBL] [Abstract] [Full Text] [Related]
8. [Clinicopathological features and diagnosis of pericytic tumors of the kidney].
He YL; Zou YW; Hu YJ; Wu J; Zhang W; Yu WJ; Li YJ; Jiang YX
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):987-992. PubMed ID: 36207911
[No Abstract] [Full Text] [Related]
9. Adrenal Cortical Carcinoma and Additional Rare Pathologic Findings in Multi-Organs in a Birt-Hogg-Dubé Syndrome Patient: With an Emphasis on the Molecular Characteristics of Adrenal Cortical Carcinoma.
Kim D; Murvelashvili N; Hamidi O; Jia L
Int J Surg Pathol; 2023 Aug; 31(5):689-694. PubMed ID: 35946080
[TBL] [Abstract] [Full Text] [Related]
10.
Gao J; Meng L; Xu Q; Zhao X; Deng Y; Fu Y; Guo S; He K; Shi J; Wang F; Zhang S; Guo H
Mol Imaging Biol; 2022 Oct; 24(5):759-768. PubMed ID: 35451707
[TBL] [Abstract] [Full Text] [Related]
11. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the Treatment of Cancer: A Review.
Unnisa A; Chettupalli AK; Hussain T; Kamal MA
Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
[TBL] [Abstract] [Full Text] [Related]
12. Thrombotic Microangiopathy, Podocytopathy, and Damage to the Renal Tubules with Severe Proteinuria and Acute Renal Dysfunction Induced by Lenvatinib.
Nakashima S; Sekine A; Sawa N; Kawamura Y; Kono K; Kinowaki K; Kawada M; Hasegawa E; Akuta N; Suzuki Y; Ohashi K; Takaichi K; Ubara Y; Hoshino J
Intern Med; 2022 Oct; 61(20):3083-3088. PubMed ID: 35342129
[TBL] [Abstract] [Full Text] [Related]
13. Role of Immunohistochemistry in the Differential Diagnosis of Pediatric Renal tumors: Expression of Cyclin D1, Beta-Catenin , pdgfr-Alpha, and PTEN.
Kepil N; Batur Ş; Kain ZE; Özcan G; Emre Ş; Özcan R; Celkan TT; Çomunoğlu N
Turk Patoloji Derg; 2022; 38(2):83-89. PubMed ID: 35147974
[TBL] [Abstract] [Full Text] [Related]
14. Insight on a new indolinone derivative as an orally bioavailable lead compound against renal cell carcinoma.
Fouad MA; Zaki MY; Lotfy RA; Mahmoud WR
Bioorg Chem; 2021 Jul; 112():104985. PubMed ID: 34020239
[TBL] [Abstract] [Full Text] [Related]
15. CRISPR-mediated ablation of overexpressed EGFR in combination with sunitinib significantly suppresses renal cell carcinoma proliferation.
Liu B; Diaz Arguello OA; Chen D; Chen S; Saber A; Haisma HJ
PLoS One; 2020; 15(5):e0232985. PubMed ID: 32413049
[TBL] [Abstract] [Full Text] [Related]
16. A phase I study investigation of metabolism, and disposition of [
Liu Y; Liu L; Liu L; Wang T; Guo L; Wang Y; Gao Z; Shu Y
Cancer Chemother Pharmacol; 2020 May; 85(5):907-915. PubMed ID: 32266457
[TBL] [Abstract] [Full Text] [Related]
17. FGFR1 is associated with c-MYC and proangiogenic molecules in metastatic renal cell carcinoma under anti-angiogenic therapy.
Park JY; Kim PJ; Shin SJ; Lee JL; Cho YM; Go H
Histopathology; 2020 May; 76(6):838-851. PubMed ID: 31990416
[TBL] [Abstract] [Full Text] [Related]
18. Renal Cell Carcinoma With Extensive Tumor Thrombus Into the Inferior Vena Cava and Right Atrium in a 70-Year-Old Man.
Oltean MA; Matuz R; Sitar-Taut A; Mihailov A; Rednic N; Tantau A; Toganel R; Minciuna IA; Orasan O; Muresan F; Cozma A
Am J Mens Health; 2019; 13(3):1557988319846404. PubMed ID: 31046582
[TBL] [Abstract] [Full Text] [Related]
19. Targeting Tyrosine kinases in Renal Cell Carcinoma: "New Bullets against Old Guys".
Alonso-Gordoa T; García-Bermejo ML; Grande E; Garrido P; Carrato A; Molina-Cerrillo J
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30999623
[TBL] [Abstract] [Full Text] [Related]
20. Whole-genome and transcriptome profiling of a metastatic thyroid-like follicular renal cell carcinoma.
Ko JJ; Grewal JK; Ng T; Lavoie JM; Thibodeau ML; Shen Y; Mungall AJ; Taylor G; Schrader KA; Jones SJM; Kollmannsberger C; Laskin J; Marra MA
Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30446580
[TBL] [Abstract] [Full Text] [Related]
[Next]